HomeTagsKIT-driven diseases

KIT-driven diseases

Sanofi Acquires Blueprint Medicines to Boost Immunology Pipeline

Sanofi announced a definitive agreement to acquire Blueprint Medicines Corporation, a U.S.-based biopharmaceutical company focused on systemic mastocytosis (SM) and other KIT-driven diseases. This...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics